Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kashuba

Showing results (271-280 of 555) with videos related to

Pageof 56
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)Arkaitz Imaz, Jordi Niubó, Mackenzie L Cottrell, et al.
European Journal of Clinical Pharmacology|March 23, 2021
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adultsLana Tran, Mina Nikanjam, Edmund V Capparelli, et al.
Journal of the International AIDS Society|April 20, 2022
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependentElias P Rosen, Claire Deleage, Nicole White, et al.
Gene|February 28, 2002
hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like proteinVladimir I Kashuba, Alexei I Protopopov, Sergei M Kvasha, et al.
Oncotarget|May 30, 2015
Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblastsSuhas D Darekar, Muhammad Mushtaq, Sreeharsha Gurrapu, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteersAwewura Kwara, Karen T Tashima, Julie B Dumond, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2022
Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study designCraig Sykes, Brian Van Horne, Justin Jones, et al.
American Journal of Pharmaceutical Education|September 6, 2018
Challenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineOlivia M Dong, Rachel M Howard, Rachel Church, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2002
Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected menNaumann I Chaudry, Joseph J Eron, Odin J Naderer, et al.
Pharmacotherapy|December 25, 2009
Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicityMaryPeace McRae, Naser L Rezk, Arlene S Bridges, et al.
Pageof 56

Showing results (271-280 of 555) with videos related to

Sort By:
Pageof 56
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)Arkaitz Imaz, Jordi Niubó, Mackenzie L Cottrell, et al.
European Journal of Clinical Pharmacology|March 23, 2021
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adultsLana Tran, Mina Nikanjam, Edmund V Capparelli, et al.
Journal of the International AIDS Society|April 20, 2022
Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependentElias P Rosen, Claire Deleage, Nicole White, et al.
Gene|February 28, 2002
hUNC93B1: a novel human gene representing a new gene family and encoding an unc-93-like proteinVladimir I Kashuba, Alexei I Protopopov, Sergei M Kvasha, et al.
Oncotarget|May 30, 2015
Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblastsSuhas D Darekar, Muhammad Mushtaq, Sreeharsha Gurrapu, et al.
Antimicrobial Agents and Chemotherapy|April 27, 2011
Modest but variable effect of rifampin on steady-state plasma pharmacokinetics of efavirenz in healthy African-American and Caucasian volunteersAwewura Kwara, Karen T Tashima, Julie B Dumond, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2022
Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study designCraig Sykes, Brian Van Horne, Justin Jones, et al.
American Journal of Pharmaceutical Education|September 6, 2018
Challenges and Solutions for Future Pharmacy Practice in the Era of Precision MedicineOlivia M Dong, Rachel M Howard, Rachel Church, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2002
Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected menNaumann I Chaudry, Joseph J Eron, Odin J Naderer, et al.
Pharmacotherapy|December 25, 2009
Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicityMaryPeace McRae, Naser L Rezk, Arlene S Bridges, et al.
Pageof 56